The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 80,143 | 4,563,962 | SH | SOLE | 4,563,962 | 0 | 0 | ||
| ADICET BIO INC | COM | 007002108 | 1,890 | 183,702 | SH | SOLE | 183,702 | 0 | 0 | ||
| AKOYA BIOSCIENCES INC | COM | 00974H104 | 7,736 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 8,325 | 408,377 | SH | SOLE | 408,377 | 0 | 0 | ||
| ALTIMMUNE INC | COM | 02155H200 | 34,475 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| ATHIRA PHARMA INC | COM | 04746L104 | 15,206 | 1,485,005 | SH | SOLE | 1,485,005 | 0 | 0 | ||
| CATABASIS PHARMACEUTICALS INC | COM | 14875P206 | 6,824 | 3,234,000 | SH | SOLE | 3,234,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC | COM | 15117B202 | 41,486 | 1,240,610 | SH | SOLE | 1,240,610 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONS ADS | 152309100 | 25,037 | 1,127,272 | SH | SOLE | 1,127,272 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 8,830 | 1,088,817 | SH | SOLE | 1,088,817 | 0 | 0 | ||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 25,136 | 976,145 | SH | SOLE | 976,145 | 0 | 0 | ||
| CVRX INC | COM | 126638105 | 17,734 | 633,370 | SH | SOLE | 633,370 | 0 | 0 | ||
| ESSA PHARMA INC | COM | 29668H708 | 17,878 | 625,754 | SH | SOLE | 625,754 | 0 | 0 | ||
| GH RESEARCH PLC | ORD SH | G3855L106 | 27,724 | 1,275,831 | SH | SOLE | 1,275,831 | 0 | 0 | ||
| GRAPHITE BIO INC | COM | 38870X104 | 49,556 | 1,612,617 | SH | SOLE | 1,612,617 | 0 | 0 | ||
| HARPOON THERAPEUTICS INC | COM | 41358P106 | 7,102 | 512,005 | SH | SOLE | 512,005 | 0 | 0 | ||
| INSTIL BIO INC | COM | 45783C101 | 132,633 | 6,865,076 | SH | SOLE | 6,865,076 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 11,565 | 272,306 | SH | SOLE | 272,306 | 0 | 0 | ||
| KINNATE BIOPHARMA INC | COM | 49705R105 | 34,292 | 1,473,014 | SH | SOLE | 1,473,014 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 11,989 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q200 | 47,394 | 2,641,809 | SH | SOLE | 2,641,809 | 0 | 0 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 42,983 | 1,536,193 | SH | SOLE | 1,536,193 | 0 | 0 | ||
| PHARVARIS NV | COM | N69605108 | 16,821 | 902,882 | SH | SOLE | 902,882 | 0 | 0 | ||
| PROVENTION BIO INC | COM | 74374N102 | 24,470 | 2,902,744 | SH | SOLE | 2,902,744 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 12,430 | 391,000 | SH | SOLE | 391,000 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 44,421 | 1,387,720 | SH | SOLE | 1,387,720 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM | 89620X506 | 19,416 | 2,001,686 | SH | SOLE | 2,001,686 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 357 | 19,495 | SH | SOLE | 19,495 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H202 | 50,549 | 16,047,286 | SH | SOLE | 16,047,286 | 0 | 0 | ||